A Multitude of Choice in Antimicrobial Screening
Crumlin, United Kingdom, October 14, 2009 --(PR.com)-- Randox have developed three biochip arrays for the detection of a variety of antimicrobial agents. These arrays enable simultaneous multi-analyte testing of up to 12 antimicrobials from a single sample. Antimicrobial Array I tests for sulphonamides, Array II for general antibiotics and Array III for nitrofurans, chloramphenicol and malachite green.
These antimicrobials are extensively used in human and veterinary medicine and their use in food producing animals could result in potentially harmful concentrations in tissue, organs and milk. This can lead to allergies for example to sulphonamide drugs which are relatively common and include skin rash, hives and anaphylaxis. Maximum residue limits have been set for the majority of these anti-microbial agents therefore screening on a regular basis is imperative.
Randox revolutionary biochip array technology is based on established ELISA principles utilising competitive chemiluminescent immunoassays. The biochip contains an array of immobilised antibodies each specific to a different antimicrobial. With as little as 50µl of urine or one gram of tissue, the antimicrobial analytes on each array can be analysed concurrently. The antimicrobial arrays are analysed on the semi-automated Evidence Investigator generating 540 tests in less than two hours. These arrays all provide excellent sensitivity, precision and recovery.
The antimicrobial arrays provide a sensitive and quantitative screening test for various antimicrobials. Randox innovative biochip array technology provides a multitude of choice for all your screening needs.
About Randox
Randox is an international diagnostics company, headquartered in the UK. Randox develop, manufacture and market clinical diagnostic products worldwide. Core products are: Biochip Array Technology; clinical chemistry analysers and reagents; quality controls and EQA; recombinant proteins and antibodies.
###
These antimicrobials are extensively used in human and veterinary medicine and their use in food producing animals could result in potentially harmful concentrations in tissue, organs and milk. This can lead to allergies for example to sulphonamide drugs which are relatively common and include skin rash, hives and anaphylaxis. Maximum residue limits have been set for the majority of these anti-microbial agents therefore screening on a regular basis is imperative.
Randox revolutionary biochip array technology is based on established ELISA principles utilising competitive chemiluminescent immunoassays. The biochip contains an array of immobilised antibodies each specific to a different antimicrobial. With as little as 50µl of urine or one gram of tissue, the antimicrobial analytes on each array can be analysed concurrently. The antimicrobial arrays are analysed on the semi-automated Evidence Investigator generating 540 tests in less than two hours. These arrays all provide excellent sensitivity, precision and recovery.
The antimicrobial arrays provide a sensitive and quantitative screening test for various antimicrobials. Randox innovative biochip array technology provides a multitude of choice for all your screening needs.
About Randox
Randox is an international diagnostics company, headquartered in the UK. Randox develop, manufacture and market clinical diagnostic products worldwide. Core products are: Biochip Array Technology; clinical chemistry analysers and reagents; quality controls and EQA; recombinant proteins and antibodies.
###
Contact
Randox Laboratories
Charlotte Jess
02842 8695748
www.randox.com
Charlotte Jess
02842 8695748
www.randox.com
Contact
Categories